Global Osteoarthritis Drug Pipeline Capsule - 2012 Update

Published by: Fore Pharma

Published: Sep. 10, 2012 - 23 Pages


Table of Contents

1. Osteoarthritis - Disease Overview
2. Osteoarthritis Pipeline Overview
3. Osteoarthritis Phase 3 Clinical Trial Pipeline Insights
4. Osteoarthritis Phase 2 Clinical Trial Pipeline Insights
5. Osteoarthritis Phase 1 Clinical Trial Pipeline Insights
6. Osteoarthritis Preclinical Research Pipeline Insights
7. Osteoarthritis Discovery Stage Pipeline Insights
8. Osteoarthritis Drug Development Activities - Geographic Landscape
8.1. Osteoarthritis R&D Activities in North America
8.2. Osteoarthritis R&D Activities in Europe
9. Osteoarthritis Pipeline - Licensing Activities
List of Tables
Table 1. Osteoarthritis Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Osteoarthritis Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Osteoarthritis Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Osteoarthritis Pipeline Molecules - Preclinical Research
Table 5. Osteoarthritis Pipeline Molecules - Drug Discovery
Table 6. Osteoarthritis R&D Activities by Geography
Table 7. Osteoarthritis Pipeline Molecules - North America
Table 8. Osteoarthritis Pipeline Molecules - Europe
Table 9. Osteoarthritis Pipeline - Licensing Activities
List of Figures
Figure 1. Osteoarthritis Pipeline Molecules by R&D Stage
Figure 2. Osteoarthritis R&D Activities by Geography

Abstract

Fore Pharma's latest report 'Global Osteoarthritis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Osteoarthritis market. It covers active Osteoarthritis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:
  • Osteoarthritis: Overview
  • Osteoarthritis Pipeline Overview
  • Osteoarthritis Phase 3 Clinical Trial Pipeline Insights
  • Osteoarthritis Phase 2 Clinical Trial Pipeline Insights
  • Osteoarthritis Phase 1 Clinical Trial Pipeline Insights
  • Osteoarthritis Preclinical Research Pipeline Insights
  • Osteoarthritis Discovery Stage Pipeline Insights
  • Geographic Landscape of Osteoarthritis R&D Activities
  • Osteoarthritis R&D Activities in North America
  • Osteoarthritis R&D Activities in Europe
  • Licensing Activities / Partnerships


Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.